Ignite Creation Date:
2025-12-24 @ 2:34 PM
Ignite Modification Date:
2026-01-07 @ 7:45 AM
Study NCT ID:
NCT03632759
Status:
COMPLETED
Last Update Posted:
2022-01-24
First Post:
2018-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
Sponsor:
Carla Greenbaum, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-13
First Submit QC Date:
None
Study First Post Date:
2018-08-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-21
Last Update Post Date:
2022-01-24
Last Update Post Date Type:
ACTUAL